• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症诱导的免疫抑制与血清Toll样受体9水平之间的关系

The Relationship Between Sepsis-induced Immunosuppression and Serum Toll-like Receptor 9 Level.

作者信息

Atalan Nazan, Acar Leyla, Yapici Nihan, Kudsioglu Turkan, Ergen Arzu, Yilmaz Seda Gulec, Isbir Turgay

机构信息

Department of Anesthesiology, Marmara University Vocational School of Health Services, Istanbul, Turkey

Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.

出版信息

In Vivo. 2018 Nov-Dec;32(6):1653-1658. doi: 10.21873/invivo.11428.

DOI:10.21873/invivo.11428
PMID:30348730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6365731/
Abstract

BACKGROUND/AIM: Our aim was to determine serum TLR-9 levels in sepsis and evaluate the relationship between sepsis and serum TLR-9 levels.

MATERIALS AND METHODS

The study group consisted of 80 consecutive patients with sepsis and 100 healthy individuals. The demographic characteristics, co-morbidities and hemodynamic data of all patients were recorded.

RESULTS

TLR-9 serum levels in sepsis were statistically significantly lower compared to the control group. It was also seen that when the lactate level was >5 mmol/l in patients in the sepsis group, the serum TLR-9 levels were substantially higher.

CONCLUSION

There is a relationship between sepsis-induced immunosuppression and serum TLR-9 levels. The host immunity system can be activated by means of TLR-9-related systems, while hyperlactatemia may play a stimulating role in the re-activation of the immune system.

摘要

背景/目的:我们的目的是测定脓毒症患者血清中TLR-9水平,并评估脓毒症与血清TLR-9水平之间的关系。

材料与方法

研究组包括80例连续的脓毒症患者和100名健康个体。记录所有患者的人口统计学特征、合并症和血流动力学数据。

结果

脓毒症患者的TLR-9血清水平与对照组相比有统计学显著降低。还发现,脓毒症组患者乳酸水平>5 mmol/l时,血清TLR-9水平显著更高。

结论

脓毒症诱导的免疫抑制与血清TLR-9水平之间存在关联。宿主免疫系统可通过TLR-9相关系统被激活,而高乳酸血症可能在免疫系统的重新激活中起刺激作用。

相似文献

1
The Relationship Between Sepsis-induced Immunosuppression and Serum Toll-like Receptor 9 Level.脓毒症诱导的免疫抑制与血清Toll样受体9水平之间的关系
In Vivo. 2018 Nov-Dec;32(6):1653-1658. doi: 10.21873/invivo.11428.
2
Analysis of Toll-like Receptor 9 Gene Polymorphisms in Sepsis.脓毒症中Toll样受体9基因多态性分析
In Vivo. 2016;30(5):639-43.
3
Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response.抑制Toll样受体9通过抑制过度的炎症反应减轻脓毒症诱导的死亡率。
Cell Immunol. 2015 Jun;295(2):92-8. doi: 10.1016/j.cellimm.2015.03.009. Epub 2015 Mar 31.
4
Harmful Roles of TLR3 and TLR9 in Cardiac Dysfunction Developing during Polymicrobial Sepsis.TLR3 和 TLR9 在多微生物脓毒症发展过程中心脏功能障碍中的有害作用。
Biomed Res Int. 2018 Sep 30;2018:4302726. doi: 10.1155/2018/4302726. eCollection 2018.
5
Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation.Toll样受体9在小鼠和人类肾上腺中的表达及其在炎症过程中的潜在影响。
J Clin Endocrinol Metab. 2007 Jul;92(7):2773-83. doi: 10.1210/jc.2006-2697. Epub 2007 May 1.
6
Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis.脓毒症患者白细胞上Toll样受体-2和-4的表达增加。
Shock. 2004 Nov;22(5):403-9. doi: 10.1097/01.shk.0000142256.23382.5d.
7
Variants in the Toll-interacting protein gene are associated with susceptibility to sepsis in the Chinese Han population.Toll 相互作用蛋白基因的变异与中国汉族人群脓毒症易感性相关。
Crit Care. 2011;15(1):R12. doi: 10.1186/cc9413. Epub 2011 Jan 10.
8
Polymorphisms in the toll-like receptor 9 gene associated with sepsis and multiple organ dysfunction after major blunt trauma.TLR9 基因多态性与严重钝性创伤后脓毒症和多器官功能障碍有关。
Br J Surg. 2011 Sep;98(9):1252-9. doi: 10.1002/bjs.7532. Epub 2011 Jun 1.
9
Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.疟疾通过干扰素-γ诱导的Toll样受体表达和功能增强引发先天性免疫反应。
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5789-94. doi: 10.1073/pnas.0809742106. Epub 2009 Mar 18.
10
Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression.Park7:脓毒症免疫抑制中巨噬细胞的新治疗靶点。
Front Immunol. 2018 Nov 13;9:2632. doi: 10.3389/fimmu.2018.02632. eCollection 2018.

引用本文的文献

1
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy.胞质核酸感应作为危重症的驱动因素:机制与治疗进展
Signal Transduct Target Ther. 2025 Mar 19;10(1):90. doi: 10.1038/s41392-025-02174-2.
2
Dysregulated dendritic cells in sepsis: functional impairment and regulated cell death.脓毒症中失调的树突状细胞:功能障碍和调节性细胞死亡。
Cell Mol Biol Lett. 2024 May 30;29(1):81. doi: 10.1186/s11658-024-00602-9.
3
Macrophage-Derived Exosomes in TLR9 Mice Ameliorate Sepsis-Induced Mitochondrial Oxidative Stress and Apoptosis in Cardiomyocytes.巨噬细胞来源的外泌体在 TLR9 小鼠中改善脓毒症诱导的心肌细胞线粒体氧化应激和凋亡。
Oxid Med Cell Longev. 2022 Oct 3;2022:5719974. doi: 10.1155/2022/5719974. eCollection 2022.
4
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.固有受体激活模式涉及 COVID-19、ALI/ARDS 和脓毒症细胞因子风暴中的 TLR 和 NLR 协同作用:综述和模型制作新的预测和治疗建议。
Int J Mol Sci. 2021 Feb 20;22(4):2108. doi: 10.3390/ijms22042108.
5
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.脓毒症相关细胞因子风暴中的 Toll 样受体及其内源性负性调节因子作为未来的免疫调节靶点。
Int Immunopharmacol. 2020 Dec;89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087. Epub 2020 Oct 12.
6
Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis.树突状细胞与免疫调节药物在败血症中的相互作用。
Genes (Basel). 2020 Mar 18;11(3):323. doi: 10.3390/genes11030323.

本文引用的文献

1
Klebsiella pneumoniae: Going on the Offense with a Strong Defense.肺炎克雷伯菌:攻防兼备。
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61. doi: 10.1128/MMBR.00078-15. Print 2016 Sep.
2
Clinical application: Restoration of immune homeostasis by autophagy as a potential therapeutic target in sepsis.临床应用:自噬恢复免疫稳态作为脓毒症潜在的治疗靶点
Exp Ther Med. 2016 Apr;11(4):1159-1167. doi: 10.3892/etm.2016.3071. Epub 2016 Feb 11.
3
A Review of GM-CSF Therapy in Sepsis.脓毒症中粒细胞-巨噬细胞集落刺激因子治疗综述
Medicine (Baltimore). 2015 Dec;94(50):e2044. doi: 10.1097/MD.0000000000002044.
4
BTLA as a biomarker and mediator of sepsis-induced immunosuppression.BTLA作为脓毒症诱导免疫抑制的生物标志物和介质。
Crit Care. 2013 Dec 9;17(6):1022. doi: 10.1186/cc13143.
5
Trial watch: Sepsis study failure highlights need for trial design rethink.试验观察:脓毒症研究失败凸显重新思考试验设计的必要性。
Nat Rev Drug Discov. 2013 May;12(5):334. doi: 10.1038/nrd4016.
6
Biomarkers in sepsis.脓毒症的生物标志物。
Curr Opin Pulm Med. 2013 May;19(3):305-9. doi: 10.1097/MCP.0b013e32835f1b49.
7
Sepsis studies need new direction.脓毒症研究需要新的方向。
Lancet Infect Dis. 2012 Jul;12(7):503-5. doi: 10.1016/S1473-3099(12)70136-6.
8
Toll-like receptor kinetics in septic shock patients: a preliminary study.脓毒性休克患者 Toll 样受体动力学:初步研究。
Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):425-33. doi: 10.1177/039463201202500212.
9
Regulation of B-cell responses by Toll-like receptors.Toll 样受体对 B 细胞反应的调节。
Immunology. 2012 Aug;136(4):370-9. doi: 10.1111/j.1365-2567.2012.03587.x.
10
The search for effective therapy for sepsis: back to the drawing board?寻找脓毒症的有效治疗方法:要从头开始吗?
JAMA. 2011 Dec 21;306(23):2614-5. doi: 10.1001/jama.2011.1853.